Here are Thursday's biggest analyst calls: Nvidia, Apple, Netflix, Micron, Amazon, Meta, Toll Brothers & more
HS 01/10/2026
Here are Thursday’s biggest calls on Wall Street: Bank of America reiterates Micron as buy Bank of America said it sees a “durable memory cycle” following earnings. ” MU delivered another strong beat/raise, reinforcing our constructive view on memory’s role in AI and increasing supply-side discipline supporting a durable cycle.” Read more. Goldman Sachs upgrades TC Energy to buy from neutral Goldman said buy the dip in shares of TC Energy . “The stock has pulled back from its highs earlier this year on the back of market concerns around the pace of gas/power demand growth and broader pressure on multiples from higher rates, but we see the selloff as overdone for three reasons.” RBC initiates Digital Turbine as outperform RBC said Digital Turbine shares are compelling. ” Digital Turbine’s focus on brand spend and its OEM relationships both create a differentiated exposure to a market that has seen its TAM continue to expand.” Goldman Sachs adds Amazon to the conviction buy list The firm said Amazon has plenty more room to run. ” AMZN is ideally positioned to benefit from both structural and cyclical tailwinds impacting the broader Tech sector yet has lagged many Tech stock peers and the broader S & P 500 over the past year, providing an attractive entry point for this perennial outperforming growth stock.” Wells Fargo upgrades BP to overweight from equal weight and downgrades Exxon to equal weight from overweight The firm said it sees more upside in BP. ” XOM could continue to see absolute upside within strong business conditions and execution across segments, but we see more upside in BP. ” Goldman Sachs upgrades Occidental Petroleum to buy from neutral Goldman said the company has a unique offering. ” OXY’s d ifferentiated advanced recovery strategy strengthens core oil and gas business.” JPMorgan initiates Kura Oncology as overweight The firm said the oncology biotech company has promising cancer treatments. “We are initiating coverage on Kura Oncology (KURA) with an OW rating and a Dec-27 price target of $30.” Mizuho upgrades BJ’s Restaurants to outperform from neutral Mizuho said in its upgrade of BJ’s it sees same-store sales growth upside. “We upgrade to Outperform from Neutral and increase our price target to $76 from $74 for these reasons: one, based on our strong checks, we increase our Q3 SSS growth estimate to 5.5% from 4.6%, above consensus of 4.3%.” UBS reiterates Nvidia as buy UBS said the stock is a top idea in the fourth quarter. ” NVDA is an exceptional wealth compounder, earning the highest Economic Profit of any company ever last year and forecasts indicate continued expansion. Wells Fargo upgrades Consolidated Edison to overweight from equal weight The firm says shares are defensive. “We’ve flagged as ED defensive diversification away from the broader AI trade with an electrification/reliability growth story which can prove out well over the next several weeks heading into midterms – ED provides some balance and normalcy as we head into the peak anti-utility midterm finale in November.” Oppenheimer initiates Vita Coco as outperform Oppenheimer said the company is an attractive growth story. “We are initiating coverage of The Vita Coco Company (COCO) with an Outperform rating and a $70 PT.” JPMorgan initiates Enliven Therapeutics as overweight JPMorgan said the biotech company is well positioned. “We are initiating coverage on Enliven Therapeutics with an OW rating and a Dec-27 price target of $75.” JPMorgan initiates Spyre Therapeutics as overweight JPMorgan said the biotech company is too attractive to ignore. “We are initiating coverage of Spyre Therapeutics (SYRE) with an Overweight rating and a $110 year-end 2027 price target.” Roth initiates Civeo as buy Roth said the workforce accommodations company is “structurally growing.” “We initiate coverage of Civeo Corporation (NYSE: CVEO) with a Buy rating and $39 price target, implying 19% upside.” Loop upgrades Dollar Tree to buy from hold Loop said the current economic backdrop is “favorable.” “We are upgrading Dollar Tree t o a Buy from a Hold rating while raising our price target to $140 from $130, implying 23% upside from current levels.” Morgan Stanley initiates Toll Brothers as overweight Morgan Stanley said it sees “resilient earnings.” “TOL’s affluent buyers and pricing power support more resilient margins and earnings, yet the stock trades at the lowest P/E in our coverage (~10x).” Read more. Deutsche Bank adds Meta to the fresh money list Deutsche said shares remain attractive. “Shares have outperformed the broader market recently upon the launch of Muse, which has taken off electrically. Looking forward, we do not think this represents the end-state, rather the beginning of a rich product cycle and as such, we think META r epresents an attractive opportunity for long-term investors.” TD Cowen initiates Teva Pharmaceuticals as buy TD Cowen said the company has an “innovative portfolio.” ” Teva is a global biopharma company that leverages both a base of generic/biosimilar products and a growing therapeutics pipeline.” JPMorgan upgrades Forbright to overweight from neutral JPMorgan says it sees balance sheet tailwinds. “We are upgrading Forbright to Overweight as the recent rate hike (and likely more to come) provides the catalyst we had been waiting for following 2Q and since the company’s IPO in June.” Citi initiates Rocket Lab as buy Citi said the space company is “uniquely positioned.” “As one of the only companies on the planet delivering regular commercial access to orbit, we believe RKLB’s proven launch vehicle deep portfolio of space technology, launch infrastructure and vertically integrated growth flywheel uniquely positions the company within the space industry landscape.” Wells Fargo adds Microsoft to the fourth quarter tactical buy list Wells raised its price target to $725 per share from $700. “We see a favorable tactical setup for MSFT shares into 4Q given a number of key catalysts, most notably realization of its AI advantage up & down the stack, upcoming Nov. Ignite conference & new segment reporting. Remain constructive into year-end, esp w/ shares at ~25x P/E.” Guggenheim reiterates Netflix as buy Guggenheim raised its price target on Netflix to $80 per share from $75. “We maintain our BUY rating ahead of 3Q26 results despite continued investor concern particularly focused on revenue trajectory and content slate.” Morgan Stanley reiterates Apple as overweight Morgan Stanley lowered its price target on Apple t o $355 per share from $360. “Following Fall product launch, we modestly raise our revenue estimates on stronger iPhone builds, Mac upside, and Services pricing. However, lower iPhone ASPs and higher memory costs largely offset, leaving FY27-FY28 EPS broadly unchanged at $10, with Agentic a potential emerging risk.” BMO initiates National Energy Services Reunited as outperform BMO said National Energy Services Reunited has growth potential. “We are initiating coverage at Outperform with a $39 target price.” Argus upgrades Regeneron to buy from hold Argus said buy the weakness. “Following a strong advance in the REGN stock price from June 2026 through early September 2026, the shares have pulled back, providing an attractive entry point for investors.”
